Management of Severe SARS-CoV-2-Associated Organizing Pneumonia With Immunoglobulins

Bimaje Akpa, DOI: 10.7759/cureus.77120  Abstract Organizing pneumonia (OP) is a pulmonary inflammatory disorder involving the alveolar airspaces and ducts and resulting in interstitial lung disease. It is usually corticosteroid responsive. There…[...]

Read More

Comparison of X-ray and CT Images of COVID-19 Caused by the Wild-Type and Alpha-Variant SARS-CoV-2

Chika Tsuchida • Ippei Sakamaki • Norichika Hashimoto •et. al., DOI: 10.7759/cureus.76493  Abstract Introduction This study aimed to determine the characteristics of coronavirus disease 2019 (COVID-19) pneumonia caused by the wild type and the alpha variant in…[...]

Read More

A Pilot Case-Control Study of Muscle and Bone Health Status in Patients Who Have Recovered From COVID-19 Infection

Shital Bhor • Dipali Ladkat • Nikhil Shah • Ketan Gondhalekar • Piyush Chaudhari • Anuradha Khadilkar, DOI: 10.7759/cureus.76283  Abstract Background: Coronavirus disease 2019 (COVID-19), resulting from the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), affects various bodily systems, including…[...]

Read More

A GABA-receptor agonist reduces pneumonitis severity, viral load, and death rate in SARS-CoV-2-infected mice

Jide Tian1*Barbara J. Dillion2Jill Henley3et. al. Gamma-aminobutyric acid (GABA) and GABA-receptors (GABA-Rs) form a major neurotransmitter system in the brain. GABA-Rs are also expressed by 1) cells of the innate…[...]

Read More